| HIR | DLR | P value | |
|---|---|---|---|
| Dose-length product (DLP) [mGy∙cm] | 176.1±37.1 | 106.4±50.0 | <0.001 |
| Volume CT dose index (CTDIvol) [mGy] | 11.5±2.2 | 6.9±3.2 | <0.001 |
| Effective dose [mSv] | 2.5±0.5 | 1.5±0.7 | <0.001 |
Figure 1. Organ-specific dose value comparison between DLR and SBIR. The use of DLR provides the potential for a 52% reduction in volume CT dose index and a mean of 53% in organ-specific reductions. Figure adapted from reference (Brady et al. 2021).
Figure 1. Dual-phase CT performed on a 7-year-old patient with suspected pancreatic trauma. Left: Coronal image from an arterial phase acquisition of the abdomen reconstructed with AiCE (0.3 mSv). Right: Coronal image from a portal venous phase acquisition of the abdomen and pelvis reconstructed with AiCE (0.5 mSv).
© CANON MEDICAL SYSTEMS CORPORATION
© CANON MEDICAL SYSTEMS CORPORATION
The site you see is the Canon Medical Global website. If you choose region / language, we will link to each regional site.